Physician profile
Patrick Morgan Lang
NPI 1316263866
$14,799.80
in general payments reported to CMS, 2019-2025
19 companies · $5,402 in 2025
The $5,402 reported for 2025 was more than what 92% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,255 · 2020: $220 · 2021: $1,613 · 2022: $3,476 · 2023: $1,279 · 2024: $555 · 2025: $5,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,094 · Food and Beverage: $2,388 · Travel and Lodging: $1,458 · Honoraria: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,094.22 |
| Food and Beverage | $2,387.84 |
| Travel and Lodging | $1,458.45 |
| Honoraria | $295.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $5,187.32 | 2021-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $4,694.69 | 2025 | |
| Medtronic USA, INC. | $2,110.17 | 2019-2020 | |
| Medtronic, INC. | $615.62 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $603.89 | 2021-2025 | Capio Rp, Axonics, Solyx Sis System |
| Astellas Pharma US INC | $480.38 | 2019-2023 | Myrbetriq, Veozah |
| Abbvie INC. | $459.29 | 2022-2025 | |
| Allergan, INC. | $111.61 | 2019-2022 | |
| Abbott Laboratories | $107.14 | 2019 | |
| Coloplast Corp | $96.42 | 2022-2025 | Restorelle, Speedicath |
| Caldera Medical, INC | $90.35 | 2022-2023 | Desara |
| Pfizer INC. | $65.70 | 2020 | |
| Urovant Sciences INC | $51.32 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $27.38 | 2025 | |
| Provepharm INC. | $24.33 | 2025 | Bludigo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $23.95 | 2020 | |
| Therapeuticsmd, INC. | $17.33 | 2022 | |
| Sumitomo Pharma America, INC. | $16.56 | 2024 | Myfembree |
| Hollister Incorporated | $16.35 | 2023 | Infyna Chic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.